Illumina [ILMN] vs Thermo Fisher [TMO] Detailed Stock Comparison
Illumina
NASDAQ
Loading...
Thermo Fisher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Illumina wins in 9 metrics, Thermo Fisher wins in 10 metrics, with 0 ties. Thermo Fisher appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Illumina | Thermo Fisher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.57 | 28.95 | Illumina |
| Price-to-Book Ratio | 6.77 | 3.74 | Thermo Fisher |
| Debt-to-Equity Ratio | 115.06 | 69.62 | Thermo Fisher |
| PEG Ratio | -0.11 | 5.10 | Illumina |
| EV/EBITDA | 24.14 | 19.56 | Thermo Fisher |
| Profit Margin (TTM) | 29.34% | 15.24% | Illumina |
| Operating Margin (TTM) | 18.79% | 17.84% | Illumina |
| EBITDA Margin (TTM) | 18.79% | 17.84% | Illumina |
| Return on Equity | 68.06% | 13.42% | Illumina |
| Return on Assets (TTM) | 4.25% | 4.97% | Thermo Fisher |
| Free Cash Flow (TTM) | $709.00M | $7.27B | Thermo Fisher |
| Dividend Yield | N/A | 0.31% | N/A |
| 1-Year Return | -22.52% | -17.51% | Thermo Fisher |
| Price-to-Sales Ratio (TTM) | 3.67 | 4.37 | Illumina |
| Enterprise Value | $16.70B | $211.60B | Thermo Fisher |
| EV/Revenue Ratio | 3.90 | 4.90 | Illumina |
| Gross Profit Margin (TTM) | 65.63% | 40.61% | Illumina |
| Revenue per Share (TTM) | $27 | $114 | Thermo Fisher |
| Earnings per Share (Diluted) | $7.90 | $17.27 | Thermo Fisher |
| Beta (Stock Volatility) | 1.37 | 0.75 | Thermo Fisher |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Illumina vs Thermo Fisher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Illumina | 2.53% | 1.69% | -0.23% | 26.40% | 8.34% | -22.25% |
| Thermo Fisher | 3.35% | 2.25% | 16.92% | 24.85% | -6.64% | -4.32% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Illumina | -22.52% | -49.04% | -70.44% | -48.12% | 131.21% | 1,588.23% |
| Thermo Fisher | -17.51% | -11.30% | 17.79% | 295.19% | 1,057.92% | 1,679.96% |
Performance & Financial Health Analysis: Illumina vs Thermo Fisher
| Metric | ILMN | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $15.72B | $188.80B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,378,370 | 2,025,021 |
| 90 Day Avg. Volume | 2,018,857 | 2,799,344 |
| Last Close | $101.80 | $499.99 |
| 52 Week Range | $68.70 - $156.66 | $385.46 - $627.88 |
| % from 52W High | -35.02% | -20.37% |
| All-Time High | $540.63 (Feb 08, 2021) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -81.17% | -25.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.05% | 0.03% |
| Quarterly Earnings Growth | -0.05% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.15% |
| Operating Margin (TTM) | 0.19% | 0.18% |
| Return on Equity (TTM) | 0.68% | 0.13% |
| Debt to Equity (MRQ) | 115.06 | 69.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.66 | $133.77 |
| Cash per Share (MRQ) | $7.52 | $16.92 |
| Operating Cash Flow (TTM) | $1.15B | $7.58B |
| Levered Free Cash Flow (TTM) | $111.38M | $5.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.31% |
| Last 12-Month Dividend | N/A | $1.21 |
Valuation & Enterprise Metrics Analysis: Illumina vs Thermo Fisher
| Metric | ILMN | TMO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.57 | 28.95 |
| Forward P/E | 22.46 | 21.29 |
| PEG Ratio | -0.11 | 5.10 |
| Price to Sales (TTM) | 3.67 | 4.37 |
| Price to Book (MRQ) | 6.77 | 3.74 |
| Market Capitalization | ||
| Market Capitalization | $15.72B | $188.80B |
| Enterprise Value | $16.70B | $211.60B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.90 | 4.90 |
| Enterprise to EBITDA | 24.14 | 19.56 |
| Risk & Other Metrics | ||
| Beta | 1.37 | 0.75 |
| Book Value per Share (MRQ) | $14.66 | $133.77 |
Financial Statements Comparison: Illumina vs Thermo Fisher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ILMN | TMO |
|---|---|---|
| Revenue/Sales | $1.04B | $10.36B |
| Cost of Goods Sold | $358.00M | $6.13B |
| Gross Profit | $683.00M | $4.24B |
| Research & Development | $252.00M | $342.00M |
| Operating Income (EBIT) | $164.00M | $1.82B |
| EBITDA | $276.00M | $2.73B |
| Pre-Tax Income | $182.00M | $1.62B |
| Income Tax | $51.00M | $95.00M |
| Net Income (Profit) | $131.00M | $1.51B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ILMN | TMO |
|---|---|---|
| Cash & Equivalents | $1.11B | $4.13B |
| Total Current Assets | $2.67B | $23.38B |
| Total Current Liabilities | $1.44B | $13.17B |
| Long-Term Debt | $2.03B | $31.37B |
| Total Shareholders Equity | $2.37B | $49.49B |
| Retained Earnings | $-1.11B | $54.45B |
| Property, Plant & Equipment | $1.19B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ILMN | TMO |
|---|---|---|
| Operating Cash Flow | $322.00M | $2.15B |
| Capital Expenditures | $-32.00M | $-350.00M |
| Free Cash Flow | $201.00M | $361.00M |
| Debt Repayment | N/A | $-838.00M |
| Common Stock Repurchase | $-200.00M | $-2.00B |
Short Interest & Institutional Ownership Analysis
| Metric | ILMN | TMO |
|---|---|---|
| Shares Short | 7.73M | 3.71M |
| Short Ratio | 3.43 | 1.14 |
| Short % of Float | 0.07% | 0.01% |
| Average Daily Volume (10 Day) | 1,378,370 | 2,025,021 |
| Average Daily Volume (90 Day) | 2,018,857 | 2,799,344 |
| Shares Outstanding | 159.00M | 380.77M |
| Float Shares | 149.35M | 376.76M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 1.03% | 0.92% |
Dividend Analysis & Yield Comparison: Illumina vs Thermo Fisher
| Metric | ILMN | TMO |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.21 |
| Last 12-Month Dividend Yield | N/A | 0.31% |
| 3-Year Avg Annual Dividend | N/A | $1.33 |
| 3-Year Avg Dividend Yield | N/A | 0.07% |
| 3-Year Total Dividends | N/A | $3.99 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |